Elon Musk’s Neuralink has recently achieved a significant milestone with its experimental vision-restoring implant, Blindsight. The U.S. Food and Drug Administration (FDA) has granted the device ...

Elon Musk’s Neuralink has implanted its brain-computer interface in five patients, with trials showing basic ...

Neuralink says the Food and Drug Administration has designated its experimental Blindsight implant as a "breakthrough device." The company is developing the technology in an attempt to restore ...

The Tesla CEO said that Neuralink, another one of his tech companies, planned on implanting its new brain chip, Blindsight, into a human patient for the first time in late 2025. Newsweek contacted ...

Neuralink's Blindsight implant aims to restore vision for individuals with complete blindness by bypassing damaged optic nerves and directly interfacing with the brain. Neuralink’s Blindsight ...

The company celebrated news of its FDA approval with a simple post on X: “We have received Breakthrough Device Designation from the FDA for Blindsight,” it said, adding a call for interested ...

Dubbed “Blindsight,” the experimental brain implant gained clearance from the US Food and Drug Administration to participate in the voluntary program. It is one of 58 devices to receive the ...

Neuralink, a neurotechnology company founded by Mr. Musk, announced in a statement on X that it had “received Breakthrough Device Designation from the FDA” for its Blindsight device. “The Blindsight ...

Neuralink recently announced that it has received "Breakthrough Device Designation" from the FDA for Blindsight, a device designed to restore vision to those who can no longer see. According to ...

Sept 17 (Reuters) - Elon Musk's brain-chip startup Neuralink said on Tuesday its experimental implant aimed at restoring vision received the U.S. Food and Drug Administration's "breakthrough ...